tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Venture Life Buys Back 51,828 Shares for Treasury Under Ongoing Programme

Story Highlights
  • Venture Life repurchased 51,828 ordinary shares at 65.84 pence, holding them in treasury.
  • Post-buyback, Venture Life has 125,302,949 voting rights outstanding, affecting shareholder disclosure thresholds.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Venture Life Buys Back 51,828 Shares for Treasury Under Ongoing Programme

Claim 50% Off TipRanks Premium

The latest announcement is out from Venture Life ( (GB:VLG) ).

Venture Life Group has repurchased 51,828 of its own ordinary shares at a volume-weighted average price of 65.84 pence per share under its ongoing share buyback programme, with the shares to be held in treasury. Following this transaction, the company has 128,812,145 ordinary shares in issue, of which 3,509,196 are held in treasury, leaving 125,302,949 voting rights in circulation, a change relevant for shareholders’ regulatory disclosures and reflecting ongoing capital management by the group.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £65.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on GB:VLG Stock

According to Spark, TipRanks’ AI Analyst, GB:VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on GB:VLG stock, click here.

More about Venture Life

Venture Life Group is a UK-headquartered international consumer self-care company operating in the global consumer healthcare sector. It focuses on proactive healthy longevity and commercialises products such as Balance Activ in women’s intimate healthcare, Earol for ENT care, Lift and Glucogel for energy and glucose management and hypoglycaemia, and the Health & Her range supporting the hormonal lifecycle, selling primarily through pharmacies, health & beauty stores, grocery multiples and e-commerce, both directly in key markets and via international distribution partners elsewhere.

Average Trading Volume: 221,289

Technical Sentiment Signal: Buy

Current Market Cap: £81.34M

For an in-depth examination of VLG stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1